Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linlin Shi

Showing results (141-150 of 162) with videos related to

Pageof 17
Sort By:
BMC Cancer|October 1, 2024
Advanced machine learning unveils CD8 + T cell genetic markers enhancing prognosis and immunotherapy efficacy in breast cancerHaodi Ma, LinLin Shi, Jiayu Zheng, et al.
Molecules (Basel, Switzerland)|September 28, 2024
Cyano-Substituted Oligo(<i>p</i>-phenylene vinylene) Derivatives with Aggregation-Induced Enhanced Emissions and Mechanofluorochromic LuminescenceXinju Zhu, Yaru Pan, Xinran Zhao, et al.
Theranostics|November 8, 2017
Cancer Nanomedicines Stabilized by π-π Stacking between Heterodimeric Prodrugs Enable Exceptionally High Drug Loading Capacity and Safer Delivery of Drug CombinationsHangxiang Wang, Jianmei Chen, Chang Xu, et al.
Journal of Colloid and Interface Science|June 12, 2025
Photothermal-responsive curcumin-loaded copper-based nanocomposites for targeted drug release and combined immunotherapyAnqi Ji, Pingjuan Yang, Beng Ma, et al.
American Journal of Cancer Research|August 8, 2024
STAC3 as a poor prognostic biomarker in renal clear cell carcinoma: relationship with immune infiltrationYingnan Zhang, Jingtao Li, Luwen Feng, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 23, 2020
Transforming a toxic drug into an efficacious nanomedicine using a lipoprodrug strategy for the treatment of patient-derived melanoma xenograftsLinlin Shi, Yuchen Wang, Qinchuan Wang, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 17, 2025
Rhodamine B-Derived Low-Toxicity Full-Color Carbon Dots with Wide Tunable High-Stable Liquid-State LasersYongqiang Zhang, Xueyan Ren, Xinran Zhao, et al.
Journal of Nanobiotechnology|December 2, 2025
Correction: NIR-responsive Cu<sub>2-x</sub>Se@Fc nanoparticles for photothermal- ferroptosis combination therapy in esophageal cancerLinlin Shi, Ying Yu, Jiayi Li, et al.
Journal of Nanobiotechnology|May 16, 2025
NIR-responsive Cu<sub>2 - x</sub>Se@Fc nanoparticles for photothermal- ferroptosis combination therapy in esophageal cancerLinlin Shi, Ying Yu, Jiayi Li, et al.
American Journal of Cancer Research|February 9, 2026
Erratum: STAC3 as a poor prognostic biomarker in renal clear cell carcinoma: relationship with immune infiltrationYingnan Zhang, Jingtao Li, Luwen Feng, et al.
Pageof 17

Showing results (141-150 of 162) with videos related to

Sort By:
Pageof 17
BMC Cancer|October 1, 2024
Advanced machine learning unveils CD8 + T cell genetic markers enhancing prognosis and immunotherapy efficacy in breast cancerHaodi Ma, LinLin Shi, Jiayu Zheng, et al.
Molecules (Basel, Switzerland)|September 28, 2024
Cyano-Substituted Oligo(<i>p</i>-phenylene vinylene) Derivatives with Aggregation-Induced Enhanced Emissions and Mechanofluorochromic LuminescenceXinju Zhu, Yaru Pan, Xinran Zhao, et al.
Theranostics|November 8, 2017
Cancer Nanomedicines Stabilized by π-π Stacking between Heterodimeric Prodrugs Enable Exceptionally High Drug Loading Capacity and Safer Delivery of Drug CombinationsHangxiang Wang, Jianmei Chen, Chang Xu, et al.
Journal of Colloid and Interface Science|June 12, 2025
Photothermal-responsive curcumin-loaded copper-based nanocomposites for targeted drug release and combined immunotherapyAnqi Ji, Pingjuan Yang, Beng Ma, et al.
American Journal of Cancer Research|August 8, 2024
STAC3 as a poor prognostic biomarker in renal clear cell carcinoma: relationship with immune infiltrationYingnan Zhang, Jingtao Li, Luwen Feng, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 23, 2020
Transforming a toxic drug into an efficacious nanomedicine using a lipoprodrug strategy for the treatment of patient-derived melanoma xenograftsLinlin Shi, Yuchen Wang, Qinchuan Wang, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 17, 2025
Rhodamine B-Derived Low-Toxicity Full-Color Carbon Dots with Wide Tunable High-Stable Liquid-State LasersYongqiang Zhang, Xueyan Ren, Xinran Zhao, et al.
Journal of Nanobiotechnology|December 2, 2025
Correction: NIR-responsive Cu<sub>2-x</sub>Se@Fc nanoparticles for photothermal- ferroptosis combination therapy in esophageal cancerLinlin Shi, Ying Yu, Jiayi Li, et al.
Journal of Nanobiotechnology|May 16, 2025
NIR-responsive Cu<sub>2 - x</sub>Se@Fc nanoparticles for photothermal- ferroptosis combination therapy in esophageal cancerLinlin Shi, Ying Yu, Jiayi Li, et al.
American Journal of Cancer Research|February 9, 2026
Erratum: STAC3 as a poor prognostic biomarker in renal clear cell carcinoma: relationship with immune infiltrationYingnan Zhang, Jingtao Li, Luwen Feng, et al.
Pageof 17